Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PreforPro for Bacterial Vaginosis
NCT05590195Phase 3Not yet recruiting
- Start
- May 2024
- Primary completion
- Mar 2025
01
Overview
Phase 3, randomised, double-blind trial in bacterial vaginosis (BV) (2 arms). Primary endpoint: Change in Nugent score at 3 months. Planned start May 2024; status: not yet recruiting.
02
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT05590195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05590195.